BioCC is a privately owned R&D company whose portfolio
contains probiotics for human health – probiotics focused on
cardiovascular diseases, allergies, and oxidative stress as well as
probiotics for the prevention of the Clostridium difficile infection.
BioCC carries out internationally recognized R&D with the
main goal of developing and commercializing novel lactic acid
bacteria for food and feed, dietary supplements, probiotic
foodstuffs and functional food compositions.
BioCC is interested in cooperation with companies who are interested in using strains in their products or selling BioCC products.
The lactic acid bacterium Lactobacillus plantarum TENSIA® helps to maintain the cardiovascular system through reduction of blood pressure. Strain can be used in foodstuff or in dietary supplements. Based on independent clinical trial in Russia (Clinic of the Institute of Nutrition, Russian Academy of Medical Sciences), the licensed product is marketed as “functional food” in Russia. BioCC has also developed dietary supplement “Heart Friendly TENSIA” which contains besides TENSIA® folic acid, vitamin B6, vitamin B12, vitamin B1, zinc, and selenium.
The lactic acid bacterium Lactobacillus plantarum INDUCIA® helps to maintain the cardiovascular system by reducing the level of LDL-cholesterol and the oxidative stress level of the human body.
BioCC offers clinical trials for testing possible functional properties of feed,
food and dietary supplements. To guarantee the best quality,
BioCC is a member of ECRIN (the European Clinical Research
Infrastructures Network) and ENPADASI (the European
Nutritional Phenotype Assessment and Data Sharing Initiative).